MAN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ManpowerGroup Inc (MAN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are signs of stabilization and improving financial performance, the technical indicators and lack of strong proprietary trading signals suggest that this is not an optimal entry point. The investor may consider holding off for a clearer upward trend or stronger buy signals.
The technical indicators are mixed to bearish. The MACD histogram is below 0 and negatively contracting, the RSI is neutral at 56.162, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near a resistance level (R1: 29.154) with key support at 27.416. This suggests limited immediate upside potential.
Analysts have upgraded the stock recently, with Argus upgrading to Buy and a $42 price target, citing improving conditions and cost-optimization strategies.
The company has partnered with AI company Hubert to enhance hiring practices, which could improve operational efficiency and attract investor interest.
Financials for Q4 2025 showed strong YoY growth in revenue (+7.12%), net income (+34.22%), and EPS (+38.30%).
The MACD and moving averages indicate bearish momentum, and the stock is near a resistance level.
Gross margin dropped by 5.19% YoY in Q4 2025, signaling potential cost pressures.
Goldman Sachs maintains a Sell rating despite raising the price target to $30, citing concerns about the broader economic environment and staffing demand.
In Q4 2025, ManpowerGroup reported revenue growth of 7.12% YoY to $4.713 billion, net income growth of 34.22% YoY to $30.2 million, and EPS growth of 38.30% YoY to $0.65. However, gross margin declined by 5.19% YoY to 16.27%, indicating some cost pressures.
Analysts are mixed but leaning positive. Argus upgraded the stock to Buy with a $42 price target, citing improving conditions and cost optimizations. Baird and BMO Capital raised their price targets to $50 and $45, respectively, with Outperform ratings. However, Goldman Sachs maintains a Sell rating with a $30 price target, and UBS remains Neutral with a $35 target.
